We studied whether microalbuminuria (30 to 140 micrograms of albumin per milliliter) would predict the later development of increased proteinuria and early mortality in Type II diabetics. During 1973, morning urine specimens of diabetic clinic patients 50 to 75 years of age whose disease had been diagnosed the age of 45 were examined for albumin level by radioimmunoassay. Seventy-six patients with albumin concentrations of 30 to 140 micrograms per milliliter were identified for long-term follow-up. They were compared with normal controls, diabetic patients with lower albumin concentrations (75 patients with concentrations less than 15 micrograms per milliliter and 53 with concentrations of 16 to 29 micrograms per milliliter), and 28 diabetic patients with higher concentrations (greater than 140). Age, duration of diabetes, treatment method, fasting blood glucose level, blood pressure, height, and weight were determined for the four diabetic groups. After nine years the group with albumin concentrations of 30 to 140 micrograms per milliliter was more likely to have clinically detectable proteinuria (greater than 400 micrograms per milliliter) than were the groups with lower concentrations. Mortality was 148 per cent higher in this group than in normal controls--comparable to the increase (116 per cent) in the group with heavy proteinuria (albumin levels greater than 140 micrograms per milliliter). In addition, mortality was increased 76 per cent in the group with albumin levels of 16 to 29 micrograms per milliliter and 37 per cent in the group with levels below 15. We conclude that microalbuminuria in patients with Type II diabetes is predictive of clinical proteinuria and increased mortality.
This article has been cited by other articles:
Guy, M., Borzomato, J. K, Newall, R. G, Kalra, P. A, Price, C. P
(2009). Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem
46: 468-476
[Abstract][Full Text]
von Eynatten, M., Liu, D., Hock, C., Oikonomou, D., Baumann, M., Allolio, B., Korosoglou, G., Morcos, M., Campean, V., Amann, K., Lutz, J., Heemann, U., Nawroth, P. P., Bierhaus, A., Humpert, P. M.
(2009). Urinary Adiponectin Excretion: A Novel Marker for Vascular Damage in Type 2 Diabetes. Diabetes
58: 2093-2099
[Abstract][Full Text]
Guan, J., Zhao, H.-L., Baum, L., Sui, Y., He, L., Wong, H., Lai, F. M. M., Tong, P. C. Y., Chan, J. C. N.
(2009). Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Nephrol Dial Transplant
24: 1889-1895
[Abstract][Full Text]
Kramer, C. K., Camargo, J., Ricardo, E. D., Almeida, F. K., Canani, L. H., Gross, J. L., Azevedo, M. J.
(2009). Does bacteriuria interfere with albuminuria measurements of patients with diabetes?. Nephrol Dial Transplant
24: 1193-1196
[Abstract][Full Text]
Cortinovis, M., Perico, N., Cattaneo, D., Remuzzi, G.
(2009). Aldosterone and progression of kidney disease. Ther Adv Cardiovasc Dis
3: 133-143
[Abstract]
van der Velde, M., Halbesma, N., de Charro, F. T., Bakker, S. J.L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T.
(2009). Screening for Albuminuria Identifies Individuals at Increased Renal Risk. J. Am. Soc. Nephrol.
20: 852-862
[Abstract][Full Text]
Gansevoort, R. T., Ritz, E.
(2009). Hermann Senator and albuminuria--forgotten pioneering work in the 19th century. Nephrol Dial Transplant
24: 1057-1062
[Abstract][Full Text]
Uehara, Y., Makino, H., Seiki, K., Urade, Y., on behalf of L-PGDS Clinical Research Group of Kid,
(2009). Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study. Nephrol Dial Transplant
24: 475-482
[Abstract][Full Text]
Forman, J. P., Fisher, N. D.L., Schopick, E. L., Curhan, G. C.
(2008). Higher Levels of Albuminuria within the Normal Range Predict Incident Hypertension. J. Am. Soc. Nephrol.
19: 1983-1988
[Abstract][Full Text]
Hadjadj, S., Fumeron, F., Roussel, R., Saulnier, P.-J., Gallois, Y., Ankotche, A., Travert, F., Khalil, C. A., Miot, A., Alhenc-Gelas, F., Lievre, M., Marre, M., on behalf of the DIABHYCAR, DIAB2NEPHROGENE, and S,
(2008). Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies . Diabetes Care
31: 1847-1852
[Abstract][Full Text]
Gaede, P., Valentine, W. J., Palmer, A. J., Tucker, D. M.D., Lammert, M., Parving, H.-H., Pedersen, O.
(2008). Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study. Diabetes Care
31: 1510-1515
[Abstract][Full Text]
Rademacher, E., Mauer, M., Jacobs, D. R. Jr, Chavers, B., Steinke, J., Sinaiko, A.
(2008). Albumin Excretion Rate in Normal Adolescents: Relation to Insulin Resistance and Cardiovascular Risk Factors and Comparisons to Type 1 Diabetes Mellitus Patients. CJASN
3: 998-1005
[Abstract][Full Text]
Danziger, J.
(2008). Importance of Low-Grade Albuminuria. Mayo Clin Proc.
83: 806-812
[Abstract][Full Text]
Navarro, J. F., Mora, C., Gomez, M., Muros, M., Lopez-Aguilar, C., Garcia, J.
(2008). Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-{alpha} and interleukin-6 in type 2 diabetic patients. Nephrol Dial Transplant
23: 919-926
[Abstract][Full Text]
Basi, S., Fesler, P., Mimran, A., Lewis, J. B.
(2008). Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?. Diabetes Care
31: S194-S201
[Full Text]
Nguyen, S., McCulloch, C., Brakeman, P., Portale, A., Hsu, C.-y.
(2008). Being Overweight Modifies the Association Between Cardiovascular Risk Factors and Microalbuminuria in Adolescents. Pediatrics
121: 37-45
[Abstract][Full Text]
Magliano, D. J., Polkinghorne, K. R., Barr, E. L.M., Su, Q., Chadban, S. J., Zimmet, P. Z., Shaw, J. E., Atkins, R. C.
(2007). HPLC-Detected Albuminuria Predicts Mortality. J. Am. Soc. Nephrol.
18: 3171-3176
[Abstract][Full Text]
Luo, Y., Chen, M., Wen, Q., Zhao, M., Zhang, B., Li, X., Wang, F., Huang, Q., Yao, C., Jiang, T., Cai, G., Fu, W.
(2006). Rapid and Simultaneous Quantification of 4 Urinary Proteins by Piezoelectric Quartz Crystal Microbalance Immunosensor Array. Clin. Chem.
52: 2273-2280
[Abstract][Full Text]
Marin, R., Rodriguez, P., Tranche, S., Redon, J., Morales-Olivas, F., Galgo, A., Brito, M. A., Mediavilla, J., Lozano, J. V., Filozof, C., the MAGAL group,
(2006). Prevalence of Abnormal Urinary Albumin Excretion Rate in Hypertensive Patients with Impaired Fasting Glucose and Its Association with Cardiovascular Disease. J. Am. Soc. Nephrol.
17: S178-S188
[Abstract][Full Text]
Redon, J., Morales-Olivas, F., Galgo, A., Brito, M. A., Mediavilla, J., Marin, R., Rodriguez, P., Tranche, S., Lozano, J. V., Filozof, C., and the MAGAL Group,
(2006). Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension. J. Am. Soc. Nephrol.
17: S236-S245
[Abstract][Full Text]
Chan, O. T.M., Herold, D. A.
(2006). Chip Electrophoresis as a Method for Quantifying Total Microalbuminuria. Clin. Chem.
52: 2141-2146
[Abstract][Full Text]
van de Wal, R. M.A., Gansevoort, R. T., van der Harst, P., Boomsma, F., Thijs Plokker, H.W., van Veldhuisen, D. J., de Jong, P. E., van Gilst, W. H., Voors, A. A.
(2006). Predictors of Angiotensin-Converting Enzyme Inhibitor-Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients. Hypertension
48: 870-876
[Abstract][Full Text]
van den Born, J., Pisa, B., Bakker, M. A. H., Celie, J. W. A. M., Straatman, C., Thomas, S., Viberti, G. C., Kjellen, L., Berden, J. H. M.
(2006). No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy. J. Biol. Chem.
281: 29606-29613
[Abstract][Full Text]
Lieb, W., Mayer, B., Stritzke, J., Doering, A., Hense, H.-W., Loewel, H., Erdmann, J., Schunkert, H.
(2006). Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: The MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant
21: 2780-2787
[Abstract][Full Text]
Sarafidis, P. A., Bakris, G. L.
(2006). Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant
21: 2366-2374
[Full Text]
Zandbergen, A. A.M., Sijbrands, E. J., Lamberts, S. W., Bootsma, A. H.
(2006). Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease. Diabetes Care
29: 1851-1855
[Abstract][Full Text]
de Zeeuw, D., Parving, H.-H., Henning, R. H.
(2006). Microalbuminuria as an Early Marker for Cardiovascular Disease. J. Am. Soc. Nephrol.
17: 2100-2105
[Abstract][Full Text]
Vasan, R. S.
(2006). Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations. Circulation
113: 2335-2362
[Full Text]
Rietveld, I, Hofman, A, Pols, H A P, van Duijn, C M, Lamberts, S W J, Janssen, J A M J L
(2006). An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with an abnormal glucose tolerance.. Eur J Endocrinol
154: 715-721
[Abstract][Full Text]
Tsakiris, A., Doumas, M., Lagatouras, D., Vyssoulis, G., Karpanou, E., Nearchou, N., Kouremenou, C., Skoufas, P.
(2006). Microalbuminuria Is Determined by Systolic and Pulse Pressure Over a 12-Year Period and Related to Peripheral Artery Disease in Normotensive and Hypertensive Subjects: The Three Areas Study in Greece (TAS-GR). ANGIOLOGY
57: 313-320
[Abstract]
Parvanova, A. I., Trevisan, R., Iliev, I. P., Dimitrov, B. D., Vedovato, M., Tiengo, A., Remuzzi, G., Ruggenenti, P.
(2006). Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion.. Diabetes
55: 1456-1462
[Abstract][Full Text]
Trevisan, R., Dodesini, A. R., Lepore, G.
(2006). Lipids and Renal Disease. J. Am. Soc. Nephrol.
17: S145-S147
[Abstract][Full Text]
Gilbert, R. E., Connelly, K., Kelly, D. J., Pollock, C. A., Krum, H.
(2006). Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes. CJASN
1: 193-208
[Abstract][Full Text]
Sviridov, D., Meilinger, B., Drake, S. K., Hoehn, G. T., Hortin, G. L.
(2006). Coelution of Other Proteins with Albumin during Size-Exclusion HPLC: Implications for Analysis of Urinary Albumin. Clin. Chem.
52: 389-397
[Abstract][Full Text]
Caramori, M. L., Fioretto, P., Mauer, M.
(2006). Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy. J. Am. Soc. Nephrol.
17: 339-352
[Abstract][Full Text]
Prepared by: British Cardiac Society, British Hype,
(2005). JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart
91: v1-v52
[Full Text]
Tillin, T., Forouhi, N., McKeigue, P., Chaturvedi, N.
(2005). Microalbuminuria and Coronary Heart Disease Risk in an Ethnically Diverse UK Population: A Prospective Cohort Study. J. Am. Soc. Nephrol.
16: 3702-3710
[Abstract][Full Text]
Bakris, G. L., Fonseca, V., Katholi, R. E., McGill, J. B., Messerli, F., Phillips, R. A., Raskin, P., Wright, J. T. Jr, Waterhouse, B., Lukas, M. A., Anderson, K. M., Bell, D. S.H., for the GEMINI Investigators,
(2005). Differential Effects of {beta}-Blockers on Albuminuria in Patients With Type 2 Diabetes. Hypertension
46: 1309-1315
[Abstract][Full Text]
Xu, J., Lee, E. T, Best, L. G, Begum, M., Knowler, W. C, Fabsitz, R. R, Howard, B. V
(2005). Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study. British Journal of Diabetes & Vascular Disease
5: 334-340
[Abstract]
Brinkman, J. W., de Zeeuw, D., Duker, J. J., Gansevoort, R. T., Kema, I. P., Hillege, H. L., de Jong, P. E., Bakker, S. J.L.
(2005). Falsely Low Urinary Albumin Concentrations after Prolonged Frozen Storage of Urine Samples. Clin. Chem.
51: 2181-2183
[Full Text]
Arnlov, J., Evans, J. C., Meigs, J. B., Wang, T. J., Fox, C. S., Levy, D., Benjamin, E. J., D'Agostino, R. B., Vasan, R. S.
(2005). Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study. Circulation
112: 969-975
[Abstract][Full Text]
Akahori, H., Ota, T., Torita, M., Ando, H., Kaneko, S., Takamura, T.
(2005). Tranilast Prevents the Progression of Experimental Diabetic Nephropathy through Suppression of Enhanced Extracellular Matrix Gene Expression. J. Pharmacol. Exp. Ther.
314: 514-521
[Abstract][Full Text]
Leitao, C. B., Canani, L. H., Bolson, P. B., Molon, M. P., Pinotti, A. F., Gross, J. L.
(2005). Urinary Albumin Excretion Rate Is Associated With Increased Ambulatory Blood Pressure in Normoalbuminuric Type 2 Diabetic Patients. Diabetes Care
28: 1724-1729
[Abstract][Full Text]
Klausen, K. P., Scharling, H., Jensen, G., Jensen, J. S.
(2005). New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death. Hypertension
46: 33-37
[Abstract][Full Text]
Baskar, V., Kamalakannan, D., Kiberd, B., Holland, M.R., Singh, B.M.
(2005). Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes. QJM
98: 427-433
[Abstract][Full Text]
Pascual, J. M., Rodilla, E., Gonzalez, C., Perez-Hoyos, S., Redon, J.
(2005). Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension. Hypertension
45: 1125-1130
[Abstract][Full Text]
Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., Westenfelder, C., Stasko, T., Brown, M.D., Carucci, J.A., Euvrard, S., Johnson, T.M., Sengelmann, R.D., Stockfleth, E., Tope, W.D., International Transplant-Skin Cancer Collaborative, , European Skin Care in Organ Transplant Patients Ne, , Asselbergs, F.W., Diercks, G.F., Hillege, H.L., van Boven, A.J., Janssen, W.M., Voors, A.A., de Zeeuw, D., de Jong, P.E., van Veldhuisen, D.J., van Gilst, W.H., Prevention of Renal and Vascular Endstage Disease,
(2005). Amelioration of Acute Renal Failure by Stem Cell Therapy--Paracrine Secretion Versus Transdifferentiation into Resident Cells: Administered Mesenchymal Stem Cells Protect against Ischemic Acute Renal Failure through Differentiation-Independent Mechanisms. Am J Physiol Renal Physiol E-pub February 15, 2005. J. Am. Soc. Nephrol.
16: 1153-1163
[Full Text]
Wu, T.-L., Chang, P.-Y., Li, C.-C., Tsao, K.-C., Sun, C.-F., Wu, J. T.
(2005). Microplate ELISA for Urine Microalbumin: Reference Values and Results in Patients with Type 2 Diabetes and Cardiovascular Disease. Annals of Clinical & Laboratory Science
35: 149-154
[Abstract][Full Text]
Wang, T. J., Evans, J. C., Meigs, J. B., Rifai, N., Fox, C. S., D'Agostino, R. B., Levy, D., Vasan, R. S.
(2005). Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression. Circulation
111: 1370-1376
[Abstract][Full Text]
Stuveling, E. M., Bakker, S. J. L., Hillege, H. L., de Jong, P. E., Gans, R. O. B., de Zeeuw, D.
(2005). Biochemical risk markers: a novel area for better prediction of renal risk?. Nephrol Dial Transplant
20: 497-508
[Full Text]
Cusick, M., Meleth, A. D., Agron, E., Fisher, M. R., Reed, G. F., Knatterud, G. L., Barton, F. B., Davis, M. D., Ferris, F. L. III, Chew, E. Y., Early Treatment Diabetic Retinopathy Study Resear,
(2005). Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27. Diabetes Care
28: 617-625
[Abstract][Full Text]
Brantsma, A. H., de Zeeuw, D., Hillege, H. L., Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., Jensen, J. S.
(2005). Letter Regarding Article by Klausen et al, "Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes" * Response. Circulation
111: e110-e111
[Full Text]
Briguori, C., Condorelli, G., Airoldi, F., Manganelli, F., Violante, A., Focaccio, A., Ricciardelli, B., Colombo, A.
(2005). Impact of microvascular complications on outcome after coronary stent implantations in patients with diabetes. J Am Coll Cardiol
45: 464-466
[Full Text]
Suarez, G A, Clark, V M, Norell, J E, Kottke, T E, Callahan, M J, O'Brien, P C, Low, P A, Dyck, P J
(2005). Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J. Neurol. Neurosurg. Psychiatry
76: 240-245
[Abstract][Full Text]
Furtner, M., Kiechl, S., Mair, A., Seppi, K., Weger, S., Oberhollenzer, F., Poewe, W., Willeit, J.
(2005). Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J
26: 279-287
[Abstract][Full Text]
Bickerton, A S T, Clark, N, Meeking, D, Shaw, K M, Crook, M, Lumb, P, Turner, C, Cummings, M H
(2005). Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J. Clin. Pathol.
58: 151-154
[Abstract][Full Text]
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., Zelmanovitz, T.
(2005). Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care
28: 164-176
[Abstract][Full Text]
Young, B. A., Katon, W. J., Von Korff, M., Simon, G. E., Lin, E. H. B., Ciechanowski, P. S., Bush, T., Oliver, M., Ludman, E. J., Boyko, E. J.
(2005). Racial and Ethnic Differences in Microalbuminuria Prevalence in a Diabetes Population: The Pathways Study. J. Am. Soc. Nephrol.
16: 219-228
[Abstract][Full Text]
Gaede, P., Pedersen, O.
(2004). Intensive Integrated Therapy of Type 2 Diabetes: Implications for Long-Term Prognosis. Diabetes
53: S39-S47
[Abstract][Full Text]
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., Ene-Iordache, B., Gaspari, F., Perna, A., Bossi, A., Trevisan, R., Dodesini, A. R., Remuzzi, G., the Bergamo Nephrologic Diabetes Complications Tri,
(2004). Preventing Microalbuminuria in Type 2 Diabetes. NEJM
351: 1941-1951
[Abstract][Full Text]
Asselbergs, F. W., Diercks, G. F.H., Hillege, H. L., van Boven, A. J., Janssen, W. M.T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., van Gilst, W. H., for the Prevention of Renal and Vascular Endstage,
(2004). Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria. Circulation
110: 2809-2816
[Abstract][Full Text]
Kim, S. H, Reaven, G. M
(2004). The metabolic syndrome: one step forward, two steps back. Diabetes and Vascular Disease Research
1: 68-75
[Abstract]
Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., Jensen, J. S.
(2004). Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes. Circulation
110: 32-35
[Abstract][Full Text]
Cohn, J. N., Quyyumi, A. A., Hollenberg, N. K., Jamerson, K. A.
(2004). Surrogate Markers for Cardiovascular Disease: Functional Markers. Circulation
109: IV-31-IV-46
[Full Text]
Svensson, M., Eriksson, J. W., Dahlquist, G.
(2004). Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabetes: A population-based study in northern Sweden. Diabetes Care
27: 955-962
[Abstract][Full Text]
Lane, J. T.
(2004). Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am. J. Physiol. Renal Physiol.
286: F442-F450
[Abstract][Full Text]
Marre, M., Lievre, M., Chatellier, G., Mann, J. F E, Passa, P., Menard, J.
(2004). Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ
328: 495-
[Abstract][Full Text]
Nakajima, H., Takenaka, M., Kaimori, J.-Y., Hamano, T., Iwatani, H., Sugaya, T., Ito, T., Hori, M., Imai, E.
(2004). Activation of the Signal Transducer and Activator of Transcription Signaling Pathway in Renal Proximal Tubular Cells by Albumin. J. Am. Soc. Nephrol.
15: 276-285
[Abstract][Full Text]
Romundstad, S., Holmen, J., Hallan, H., Kvenild, K., Ellekjaer, H.
(2003). Microalbuminuria and All-Cause Mortality in Treated Hypertensive Individuals: Does Sex Matter?: The Nord-Trondelag Health Study (HUNT), Norway. Circulation
108: 2783-2789
[Abstract][Full Text]
Singleton, J. R., Smith, A. G., Russell, J. W., Feldman, E. L.
(2003). Microvascular Complications of Impaired Glucose Tolerance. Diabetes
52: 2867-2873
[Abstract][Full Text]
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., Wilson, P. W.
(2003). Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension
42: 1050-1065
[Full Text]
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., Wilson, P. W.
(2003). Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation
108: 2154-2169
[Full Text]
Atkins, R. C., Briganti, E. M., Zimmet, P. Z., Chadban, S. J.
(2003). Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant
18: 2170-2174
[Abstract][Full Text]
Murtaugh, M. A., Jacobs, D. R. Jr., Yu, X., Gross, M. D., Steffes, M.
(2003). Correlates of Urinary Albumin Excretion in Young Adult Blacks and Whites: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol
158: 676-686
[Abstract][Full Text]
Svensson, M., Sundkvist, G., Arnqvist, H. J., Bjork, E., Blohme, G., Bolinder, J., Henricsson, M., Nystrom, L., Torffvit, O., Waernbaum, I., Ostman, J., Eriksson, J. W.
(2003). Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care
26: 2903-2909
[Abstract][Full Text]
Kaimori, J.-y., Takenaka, M., Nakajima, H., Hamano, T., Horio, M., Sugaya, T., Ito, T., Hori, M., Okubo, K., Imai, E.
(2003). Induction of Glia Maturation Factor-{beta} in Proximal Tubular Cells Leads to Vulnerability to Oxidative Injury through the p38 Pathway and Changes in Antioxidant Enzyme Activities. J. Biol. Chem.
278: 33519-33527
[Abstract][Full Text]
McDonald, S. P., Maguire, G. P., Hoy, W. E.
(2003). Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant
18: 1555-1561
[Abstract][Full Text]
McDonald, S. P., Maguire, G. P., Hoy, W. E.
(2003). Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant
18: 1555-1561
[Abstract][Full Text]
Zandbergen, A. A.M., Baggen, M. G.A., Lamberts, S. W.J., Bootsma, A. H., de Zeeuw, D., Ouwendijk, R. J.Th.
(2003). Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. ANN INTERN MED
139: 90-96
[Abstract][Full Text]
Walker, J. D
(2003). Commentary: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy?. British Journal of Diabetes & Vascular Disease
3: 282-284
[Abstract]
Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Pagano, G., Perin, P. C.
(2003). Progression to Overt Nephropathy in Type 2 Diabetes: The Casale Monferrato Study. Diabetes Care
26: 2150-2155
[Abstract][Full Text]
Arar, N. H., Hazuda, H. P., Plaetke, R., Sartorio, V., Arar, M. Y., Abboud, H. E.
(2003). Familial Clustering of Diabetic Nephropathy: Perceptions and Risk Recognition Among Mexican-American Patients With a Family History of Diabetes. Diabetes Spectr.
16: 136-142
[Abstract][Full Text]
Liu, J. E., Robbins, D. C., Palmieri, V., Bella, J. N., Roman, M. J., Fabsitz, R., Howard, B. V., Welty, T. K., Lee, E. T., Devereux, R. B.
(2003). Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: The Strong Heart Study. J Am Coll Cardiol
41: 2022-2028
[Abstract][Full Text]
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., Stein, G., Bierhaus, A., Liliensiek, B., Arnold, B., Nawroth, P. P., Stern, D. M., D'Agati, V. D., Schmidt, A. M.
(2003). RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy. Am. J. Pathol.
162: 1123-1137
[Abstract][Full Text]
Perassolo, M. S., Almeida, J. C., Pra, R. L., Mello, V. D., Maia, A. L., Moulin, C. C., Camargo, J. L., Zelmanovitz, T., Azevedo, M. J., Gross, J. L.
(2003). Fatty Acid Composition of Serum Lipid Fractions in Type 2 Diabetic Patients With Microalbuminuria. Diabetes Care
26: 613-618
[Abstract][Full Text]
Gaede, P., Vedel, P., Larsen, N., Jensen, G. V.H., Parving, H.-H., Pedersen, O.
(2003). Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. NEJM
348: 383-393
[Abstract][Full Text]
de Jong, P. E., Hillege, H. L., Pinto-Sietsma, S. J., de Zeeuw, D.
(2003). Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?. Nephrol Dial Transplant
18: 10-13
[Full Text]
Cameron, J S.
(2003). Fifty years of established diabetic nephropathy -- a personal perspective. British Journal of Diabetes & Vascular Disease
3: 8-16
Penders, J., Fiers, T., Delanghe, J. R.
(2002). Quantitative Evaluation of Urinalysis Test Strips. Clin. Chem.
48: 2236-2241
[Abstract][Full Text]
Lepore, G., Maglio, M. L., Nosari, I., Dodesini, A. R., Trevisan, R.
(2002). Cost-Effectiveness of Two Screening Programs for Microalbuminuria in Type 2 Diabetes. Diabetes Care
25: 2103-2104
[Full Text]
Elisaf, M., Mikhailidis, D. P.
(2002). Statins and Renal Function. ANGIOLOGY
53: 493-502
[Abstract]
Opie, L. H., Parving, H.-H.
(2002). Diabetic Nephropathy: Can Renoprotection Be Extrapolated to Cardiovascular Protection?. Circulation
106: 643-645
[Full Text]
Previous
